Global Psychedelic Medicine Supply, Demand and Key Producers, 2023-2029
Page: 129
Published Date: 23 Jan 2023
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Psychedelic Medicine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Psychedelic Medicine demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Psychedelic Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Psychedelic Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Psychedelic Medicine total market, 2018-2029, (USD Million)
Global Psychedelic Medicine total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Psychedelic Medicine total market, key domestic companies and share, (USD Million)
Global Psychedelic Medicine revenue by player and market share 2018-2023, (USD Million)
Global Psychedelic Medicine total market by Type, CAGR, 2018-2029, (USD Million)
Global Psychedelic Medicine total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Psychedelic Medicine market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include COMPASS Pathways PLC, Pfizer, Eli Lilly, GlaxoSmithKline, Cybin Inc, Field Trip Health, ATAI Life Sciences, NUMINUS WELLNESS and MindMed, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Psychedelic Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Psychedelic Medicine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Psychedelic Medicine Market, Segmentation by Type
Psilocybin
LSD
MDMA
DMT
Ketamine
Others
Global Psychedelic Medicine Market, Segmentation by Application
Depressive Disorders
Post-Traumatic Stress Disorders
Substance Abuse Disorders
Obsessive Compulsive Disorders
Others
Companies Profiled:
COMPASS Pathways PLC
Pfizer
Eli Lilly
GlaxoSmithKline
Cybin Inc
Field Trip Health
ATAI Life Sciences
NUMINUS WELLNESS
MindMed
HAVN Life Sciences
Seelos Therapeutics
Jannsen
Acadia Pharmaceuticals
Intellipharmaceutics
Revive Therapeutics
Mydecine Innovations Group
Red Light Holland
Braxia Scientific
Mind Cure Health
Entheon Biomedical
Key Questions Answered
1. How big is the global Psychedelic Medicine market?
2. What is the demand of the global Psychedelic Medicine market?
3. What is the year over year growth of the global Psychedelic Medicine market?
4. What is the total value of the global Psychedelic Medicine market?
5. Who are the major players in the global Psychedelic Medicine market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Psychedelic Medicine Introduction
1.2 World Psychedelic Medicine Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Psychedelic Medicine Total Market by Region (by Headquarter Location)
1.3.1 World Psychedelic Medicine Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Psychedelic Medicine Market Size (2018-2029)
1.3.3 China Psychedelic Medicine Market Size (2018-2029)
1.3.4 Europe Psychedelic Medicine Market Size (2018-2029)
1.3.5 Japan Psychedelic Medicine Market Size (2018-2029)
1.3.6 South Korea Psychedelic Medicine Market Size (2018-2029)
1.3.7 ASEAN Psychedelic Medicine Market Size (2018-2029)
1.3.8 India Psychedelic Medicine Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Psychedelic Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Psychedelic Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2.1 World Psychedelic Medicine Consumption Value (2018-2029)
2.2 World Psychedelic Medicine Consumption Value by Region
2.2.1 World Psychedelic Medicine Consumption Value by Region (2018-2023)
2.2.2 World Psychedelic Medicine Consumption Value Forecast by Region (2024-2029)
2.3 United States Psychedelic Medicine Consumption Value (2018-2029)
2.4 China Psychedelic Medicine Consumption Value (2018-2029)
2.5 Europe Psychedelic Medicine Consumption Value (2018-2029)
2.6 Japan Psychedelic Medicine Consumption Value (2018-2029)
2.7 South Korea Psychedelic Medicine Consumption Value (2018-2029)
2.8 ASEAN Psychedelic Medicine Consumption Value (2018-2029)
2.9 India Psychedelic Medicine Consumption Value (2018-2029)
3.1 World Psychedelic Medicine Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Psychedelic Medicine Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Psychedelic Medicine in 2022
3.2.3 Global Concentration Ratios (CR8) for Psychedelic Medicine in 2022
3.3 Psychedelic Medicine Company Evaluation Quadrant
3.4 Psychedelic Medicine Market: Overall Company Footprint Analysis
3.4.1 Psychedelic Medicine Market: Region Footprint
3.4.2 Psychedelic Medicine Market: Company Product Type Footprint
3.4.3 Psychedelic Medicine Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4.1 United States VS China: Psychedelic Medicine Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Psychedelic Medicine Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Psychedelic Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Psychedelic Medicine Consumption Value Comparison
4.2.1 United States VS China: Psychedelic Medicine Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Psychedelic Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Psychedelic Medicine Companies and Market Share, 2018-2023
4.3.1 United States Based Psychedelic Medicine Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Psychedelic Medicine Revenue, (2018-2023)
4.4 China Based Companies Psychedelic Medicine Revenue and Market Share, 2018-2023
4.4.1 China Based Psychedelic Medicine Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Psychedelic Medicine Revenue, (2018-2023)
4.5 Rest of World Based Psychedelic Medicine Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Psychedelic Medicine Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Psychedelic Medicine Revenue, (2018-2023)
5.1 World Psychedelic Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Psilocybin
5.2.2 LSD
5.2.3 MDMA
5.2.4 DMT
5.2.5 Ketamine
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Psychedelic Medicine Market Size by Type (2018-2023)
5.3.2 World Psychedelic Medicine Market Size by Type (2024-2029)
5.3.3 World Psychedelic Medicine Market Size Market Share by Type (2018-2029)
6.1 World Psychedelic Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Depressive Disorders
6.2.2 Post-Traumatic Stress Disorders
6.2.3 Substance Abuse Disorders
6.2.4 Obsessive Compulsive Disorders
6.2.5 Obsessive Compulsive Disorders
6.3 Market Segment by Application
6.3.1 World Psychedelic Medicine Market Size by Application (2018-2023)
6.3.2 World Psychedelic Medicine Market Size by Application (2024-2029)
6.3.3 World Psychedelic Medicine Market Size by Application (2018-2029)
7.1 COMPASS Pathways PLC
7.1.1 COMPASS Pathways PLC Details
7.1.2 COMPASS Pathways PLC Major Business
7.1.3 COMPASS Pathways PLC Psychedelic Medicine Product and Services
7.1.4 COMPASS Pathways PLC Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 COMPASS Pathways PLC Recent Developments/Updates
7.1.6 COMPASS Pathways PLC Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Psychedelic Medicine Product and Services
7.2.4 Pfizer Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Eli Lilly
7.3.1 Eli Lilly Details
7.3.2 Eli Lilly Major Business
7.3.3 Eli Lilly Psychedelic Medicine Product and Services
7.3.4 Eli Lilly Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Eli Lilly Recent Developments/Updates
7.3.6 Eli Lilly Competitive Strengths & Weaknesses
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Details
7.4.2 GlaxoSmithKline Major Business
7.4.3 GlaxoSmithKline Psychedelic Medicine Product and Services
7.4.4 GlaxoSmithKline Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 GlaxoSmithKline Recent Developments/Updates
7.4.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.5 Cybin Inc
7.5.1 Cybin Inc Details
7.5.2 Cybin Inc Major Business
7.5.3 Cybin Inc Psychedelic Medicine Product and Services
7.5.4 Cybin Inc Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Cybin Inc Recent Developments/Updates
7.5.6 Cybin Inc Competitive Strengths & Weaknesses
7.6 Field Trip Health
7.6.1 Field Trip Health Details
7.6.2 Field Trip Health Major Business
7.6.3 Field Trip Health Psychedelic Medicine Product and Services
7.6.4 Field Trip Health Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Field Trip Health Recent Developments/Updates
7.6.6 Field Trip Health Competitive Strengths & Weaknesses
7.7 ATAI Life Sciences
7.7.1 ATAI Life Sciences Details
7.7.2 ATAI Life Sciences Major Business
7.7.3 ATAI Life Sciences Psychedelic Medicine Product and Services
7.7.4 ATAI Life Sciences Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 ATAI Life Sciences Recent Developments/Updates
7.7.6 ATAI Life Sciences Competitive Strengths & Weaknesses
7.8 NUMINUS WELLNESS
7.8.1 NUMINUS WELLNESS Details
7.8.2 NUMINUS WELLNESS Major Business
7.8.3 NUMINUS WELLNESS Psychedelic Medicine Product and Services
7.8.4 NUMINUS WELLNESS Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 NUMINUS WELLNESS Recent Developments/Updates
7.8.6 NUMINUS WELLNESS Competitive Strengths & Weaknesses
7.9 MindMed
7.9.1 MindMed Details
7.9.2 MindMed Major Business
7.9.3 MindMed Psychedelic Medicine Product and Services
7.9.4 MindMed Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 MindMed Recent Developments/Updates
7.9.6 MindMed Competitive Strengths & Weaknesses
7.10 HAVN Life Sciences
7.10.1 HAVN Life Sciences Details
7.10.2 HAVN Life Sciences Major Business
7.10.3 HAVN Life Sciences Psychedelic Medicine Product and Services
7.10.4 HAVN Life Sciences Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 HAVN Life Sciences Recent Developments/Updates
7.10.6 HAVN Life Sciences Competitive Strengths & Weaknesses
7.11 Seelos Therapeutics
7.11.1 Seelos Therapeutics Details
7.11.2 Seelos Therapeutics Major Business
7.11.3 Seelos Therapeutics Psychedelic Medicine Product and Services
7.11.4 Seelos Therapeutics Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Seelos Therapeutics Recent Developments/Updates
7.11.6 Seelos Therapeutics Competitive Strengths & Weaknesses
7.12 Jannsen
7.12.1 Jannsen Details
7.12.2 Jannsen Major Business
7.12.3 Jannsen Psychedelic Medicine Product and Services
7.12.4 Jannsen Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Jannsen Recent Developments/Updates
7.12.6 Jannsen Competitive Strengths & Weaknesses
7.13 Acadia Pharmaceuticals
7.13.1 Acadia Pharmaceuticals Details
7.13.2 Acadia Pharmaceuticals Major Business
7.13.3 Acadia Pharmaceuticals Psychedelic Medicine Product and Services
7.13.4 Acadia Pharmaceuticals Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Acadia Pharmaceuticals Recent Developments/Updates
7.13.6 Acadia Pharmaceuticals Competitive Strengths & Weaknesses
7.14 Intellipharmaceutics
7.14.1 Intellipharmaceutics Details
7.14.2 Intellipharmaceutics Major Business
7.14.3 Intellipharmaceutics Psychedelic Medicine Product and Services
7.14.4 Intellipharmaceutics Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Intellipharmaceutics Recent Developments/Updates
7.14.6 Intellipharmaceutics Competitive Strengths & Weaknesses
7.15 Revive Therapeutics
7.15.1 Revive Therapeutics Details
7.15.2 Revive Therapeutics Major Business
7.15.3 Revive Therapeutics Psychedelic Medicine Product and Services
7.15.4 Revive Therapeutics Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Revive Therapeutics Recent Developments/Updates
7.15.6 Revive Therapeutics Competitive Strengths & Weaknesses
7.16 Mydecine Innovations Group
7.16.1 Mydecine Innovations Group Details
7.16.2 Mydecine Innovations Group Major Business
7.16.3 Mydecine Innovations Group Psychedelic Medicine Product and Services
7.16.4 Mydecine Innovations Group Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Mydecine Innovations Group Recent Developments/Updates
7.16.6 Mydecine Innovations Group Competitive Strengths & Weaknesses
7.17 Red Light Holland
7.17.1 Red Light Holland Details
7.17.2 Red Light Holland Major Business
7.17.3 Red Light Holland Psychedelic Medicine Product and Services
7.17.4 Red Light Holland Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Red Light Holland Recent Developments/Updates
7.17.6 Red Light Holland Competitive Strengths & Weaknesses
7.18 Braxia Scientific
7.18.1 Braxia Scientific Details
7.18.2 Braxia Scientific Major Business
7.18.3 Braxia Scientific Psychedelic Medicine Product and Services
7.18.4 Braxia Scientific Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Braxia Scientific Recent Developments/Updates
7.18.6 Braxia Scientific Competitive Strengths & Weaknesses
7.19 Mind Cure Health
7.19.1 Mind Cure Health Details
7.19.2 Mind Cure Health Major Business
7.19.3 Mind Cure Health Psychedelic Medicine Product and Services
7.19.4 Mind Cure Health Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Mind Cure Health Recent Developments/Updates
7.19.6 Mind Cure Health Competitive Strengths & Weaknesses
7.20 Entheon Biomedical
7.20.1 Entheon Biomedical Details
7.20.2 Entheon Biomedical Major Business
7.20.3 Entheon Biomedical Psychedelic Medicine Product and Services
7.20.4 Entheon Biomedical Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Entheon Biomedical Recent Developments/Updates
7.20.6 Entheon Biomedical Competitive Strengths & Weaknesses
8.1 Psychedelic Medicine Industry Chain
8.2 Psychedelic Medicine Upstream Analysis
8.3 Psychedelic Medicine Midstream Analysis
8.4 Psychedelic Medicine Downstream Analysis
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Psychedelic Medicine Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Psychedelic Medicine Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Psychedelic Medicine Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Psychedelic Medicine Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Psychedelic Medicine Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Psychedelic Medicine Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Psychedelic Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Psychedelic Medicine Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Psychedelic Medicine Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Psychedelic Medicine Players in 2022
Table 12. World Psychedelic Medicine Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Psychedelic Medicine Company Evaluation Quadrant
Table 14. Head Office of Key Psychedelic Medicine Player
Table 15. Psychedelic Medicine Market: Company Product Type Footprint
Table 16. Psychedelic Medicine Market: Company Product Application Footprint
Table 17. Psychedelic Medicine Mergers & Acquisitions Activity
Table 18. United States VS China Psychedelic Medicine Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Psychedelic Medicine Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Psychedelic Medicine Companies, Headquarters (States, Country)
Table 21. United States Based Companies Psychedelic Medicine Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Psychedelic Medicine Revenue Market Share (2018-2023)
Table 23. China Based Psychedelic Medicine Companies, Headquarters (Province, Country)
Table 24. China Based Companies Psychedelic Medicine Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Psychedelic Medicine Revenue Market Share (2018-2023)
Table 26. Rest of World Based Psychedelic Medicine Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Psychedelic Medicine Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Psychedelic Medicine Revenue Market Share (2018-2023)
Table 29. World Psychedelic Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Psychedelic Medicine Market Size by Type (2018-2023) & (USD Million)
Table 31. World Psychedelic Medicine Market Size by Type (2024-2029) & (USD Million)
Table 32. World Psychedelic Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Psychedelic Medicine Market Size by Application (2018-2023) & (USD Million)
Table 34. World Psychedelic Medicine Market Size by Application (2024-2029) & (USD Million)
Table 35. COMPASS Pathways PLC Basic Information, Area Served and Competitors
Table 36. COMPASS Pathways PLC Major Business
Table 37. COMPASS Pathways PLC Psychedelic Medicine Product and Services
Table 38. COMPASS Pathways PLC Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. COMPASS Pathways PLC Recent Developments/Updates
Table 40. COMPASS Pathways PLC Competitive Strengths & Weaknesses
Table 41. Pfizer Basic Information, Area Served and Competitors
Table 42. Pfizer Major Business
Table 43. Pfizer Psychedelic Medicine Product and Services
Table 44. Pfizer Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Pfizer Recent Developments/Updates
Table 46. Pfizer Competitive Strengths & Weaknesses
Table 47. Eli Lilly Basic Information, Area Served and Competitors
Table 48. Eli Lilly Major Business
Table 49. Eli Lilly Psychedelic Medicine Product and Services
Table 50. Eli Lilly Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Eli Lilly Recent Developments/Updates
Table 52. Eli Lilly Competitive Strengths & Weaknesses
Table 53. GlaxoSmithKline Basic Information, Area Served and Competitors
Table 54. GlaxoSmithKline Major Business
Table 55. GlaxoSmithKline Psychedelic Medicine Product and Services
Table 56. GlaxoSmithKline Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. GlaxoSmithKline Recent Developments/Updates
Table 58. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 59. Cybin Inc Basic Information, Area Served and Competitors
Table 60. Cybin Inc Major Business
Table 61. Cybin Inc Psychedelic Medicine Product and Services
Table 62. Cybin Inc Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Cybin Inc Recent Developments/Updates
Table 64. Cybin Inc Competitive Strengths & Weaknesses
Table 65. Field Trip Health Basic Information, Area Served and Competitors
Table 66. Field Trip Health Major Business
Table 67. Field Trip Health Psychedelic Medicine Product and Services
Table 68. Field Trip Health Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Field Trip Health Recent Developments/Updates
Table 70. Field Trip Health Competitive Strengths & Weaknesses
Table 71. ATAI Life Sciences Basic Information, Area Served and Competitors
Table 72. ATAI Life Sciences Major Business
Table 73. ATAI Life Sciences Psychedelic Medicine Product and Services
Table 74. ATAI Life Sciences Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. ATAI Life Sciences Recent Developments/Updates
Table 76. ATAI Life Sciences Competitive Strengths & Weaknesses
Table 77. NUMINUS WELLNESS Basic Information, Area Served and Competitors
Table 78. NUMINUS WELLNESS Major Business
Table 79. NUMINUS WELLNESS Psychedelic Medicine Product and Services
Table 80. NUMINUS WELLNESS Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. NUMINUS WELLNESS Recent Developments/Updates
Table 82. NUMINUS WELLNESS Competitive Strengths & Weaknesses
Table 83. MindMed Basic Information, Area Served and Competitors
Table 84. MindMed Major Business
Table 85. MindMed Psychedelic Medicine Product and Services
Table 86. MindMed Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. MindMed Recent Developments/Updates
Table 88. MindMed Competitive Strengths & Weaknesses
Table 89. HAVN Life Sciences Basic Information, Area Served and Competitors
Table 90. HAVN Life Sciences Major Business
Table 91. HAVN Life Sciences Psychedelic Medicine Product and Services
Table 92. HAVN Life Sciences Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. HAVN Life Sciences Recent Developments/Updates
Table 94. HAVN Life Sciences Competitive Strengths & Weaknesses
Table 95. Seelos Therapeutics Basic Information, Area Served and Competitors
Table 96. Seelos Therapeutics Major Business
Table 97. Seelos Therapeutics Psychedelic Medicine Product and Services
Table 98. Seelos Therapeutics Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Seelos Therapeutics Recent Developments/Updates
Table 100. Seelos Therapeutics Competitive Strengths & Weaknesses
Table 101. Jannsen Basic Information, Area Served and Competitors
Table 102. Jannsen Major Business
Table 103. Jannsen Psychedelic Medicine Product and Services
Table 104. Jannsen Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Jannsen Recent Developments/Updates
Table 106. Jannsen Competitive Strengths & Weaknesses
Table 107. Acadia Pharmaceuticals Basic Information, Area Served and Competitors
Table 108. Acadia Pharmaceuticals Major Business
Table 109. Acadia Pharmaceuticals Psychedelic Medicine Product and Services
Table 110. Acadia Pharmaceuticals Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Acadia Pharmaceuticals Recent Developments/Updates
Table 112. Acadia Pharmaceuticals Competitive Strengths & Weaknesses
Table 113. Intellipharmaceutics Basic Information, Area Served and Competitors
Table 114. Intellipharmaceutics Major Business
Table 115. Intellipharmaceutics Psychedelic Medicine Product and Services
Table 116. Intellipharmaceutics Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Intellipharmaceutics Recent Developments/Updates
Table 118. Intellipharmaceutics Competitive Strengths & Weaknesses
Table 119. Revive Therapeutics Basic Information, Area Served and Competitors
Table 120. Revive Therapeutics Major Business
Table 121. Revive Therapeutics Psychedelic Medicine Product and Services
Table 122. Revive Therapeutics Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Revive Therapeutics Recent Developments/Updates
Table 124. Revive Therapeutics Competitive Strengths & Weaknesses
Table 125. Mydecine Innovations Group Basic Information, Area Served and Competitors
Table 126. Mydecine Innovations Group Major Business
Table 127. Mydecine Innovations Group Psychedelic Medicine Product and Services
Table 128. Mydecine Innovations Group Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Mydecine Innovations Group Recent Developments/Updates
Table 130. Mydecine Innovations Group Competitive Strengths & Weaknesses
Table 131. Red Light Holland Basic Information, Area Served and Competitors
Table 132. Red Light Holland Major Business
Table 133. Red Light Holland Psychedelic Medicine Product and Services
Table 134. Red Light Holland Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Red Light Holland Recent Developments/Updates
Table 136. Red Light Holland Competitive Strengths & Weaknesses
Table 137. Braxia Scientific Basic Information, Area Served and Competitors
Table 138. Braxia Scientific Major Business
Table 139. Braxia Scientific Psychedelic Medicine Product and Services
Table 140. Braxia Scientific Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Braxia Scientific Recent Developments/Updates
Table 142. Braxia Scientific Competitive Strengths & Weaknesses
Table 143. Mind Cure Health Basic Information, Area Served and Competitors
Table 144. Mind Cure Health Major Business
Table 145. Mind Cure Health Psychedelic Medicine Product and Services
Table 146. Mind Cure Health Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Mind Cure Health Recent Developments/Updates
Table 148. Entheon Biomedical Basic Information, Area Served and Competitors
Table 149. Entheon Biomedical Major Business
Table 150. Entheon Biomedical Psychedelic Medicine Product and Services
Table 151. Entheon Biomedical Psychedelic Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Psychedelic Medicine Upstream (Raw Materials)
Table 153. Psychedelic Medicine Typical Customers
List of Figure
Figure 1. Psychedelic Medicine Picture
Figure 2. World Psychedelic Medicine Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Psychedelic Medicine Total Market Size (2018-2029) & (USD Million)
Figure 4. World Psychedelic Medicine Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Psychedelic Medicine Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Psychedelic Medicine Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Psychedelic Medicine Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Psychedelic Medicine Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Psychedelic Medicine Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Psychedelic Medicine Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Psychedelic Medicine Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Psychedelic Medicine Revenue (2018-2029) & (USD Million)
Figure 13. Psychedelic Medicine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Psychedelic Medicine Consumption Value (2018-2029) & (USD Million)
Figure 16. World Psychedelic Medicine Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Psychedelic Medicine Consumption Value (2018-2029) & (USD Million)
Figure 18. China Psychedelic Medicine Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Psychedelic Medicine Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Psychedelic Medicine Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Psychedelic Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Psychedelic Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. India Psychedelic Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Psychedelic Medicine by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Psychedelic Medicine Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Psychedelic Medicine Markets in 2022
Figure 27. United States VS China: Psychedelic Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Psychedelic Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Psychedelic Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Psychedelic Medicine Market Size Market Share by Type in 2022
Figure 31. Psilocybin
Figure 32. LSD
Figure 33. MDMA
Figure 34. DMT
Figure 35. Ketamine
Figure 36. Others
Figure 37. World Psychedelic Medicine Market Size Market Share by Type (2018-2029)
Figure 38. World Psychedelic Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 39. World Psychedelic Medicine Market Size Market Share by Application in 2022
Figure 40. Depressive Disorders
Figure 41. Post-Traumatic Stress Disorders
Figure 42. Substance Abuse Disorders
Figure 43. Obsessive Compulsive Disorders
Figure 44. Others
Figure 45. Psychedelic Medicine Industrial Chain
Figure 46. Methodology
Figure 47. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
COMPASS Pathways PLC Pfizer Eli Lilly GlaxoSmithKline Cybin Inc Field Trip Health ATAI Life Sciences NUMINUS WELLNESS MindMed HAVN Life Sciences Seelos Therapeutics Jannsen Acadia Pharmaceuticals Intellipharmaceutics Revive Therapeutics Mydecine Innovations Group Red Light Holland Braxia Scientific Mind Cure Health Entheon Biomedical
Related Reports
10 Jan 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
